Swedbank AB Sells 5,716 Shares of HCA Healthcare, Inc. $HCA

Swedbank AB reduced its position in HCA Healthcare, Inc. (NYSE:HCA) by 3.9% during the first quarter, HoldingsChannel.com reports. The institutional investor owned 141,582 shares of the company’s stock after selling 5,716 shares during the period. Swedbank AB’s holdings in HCA Healthcare were worth $67,002,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of the company. Holos Integrated Wealth LLC purchased a new stake in shares of HCA Healthcare during the 4th quarter valued at about $29,000. Palisade Asset Management LLC bought a new stake in HCA Healthcare during the third quarter valued at approximately $26,000. Ares Financial Consulting LLC purchased a new position in shares of HCA Healthcare during the 4th quarter worth $31,000. MCF Advisors LLC raised its holdings in HCA Healthcare by 213.0% in the 4th quarter. MCF Advisors LLC now owns 72 shares of the company’s stock worth $34,000 after purchasing an additional 49 shares during the period. Finally, Aventura Private Wealth LLC bought a new stake in HCA Healthcare during the fourth quarter valued at about $34,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA is continuing to expand hospital, emergency room and outpatient capacity, with new investment aimed at meeting future healthcare demand and driving long-term growth. Can HCA’s Capacity Expansion Strategy Fuel Its Long-Term Growth?
• Positive Sentiment: HCA Healthcare was highlighted as a stock to watch on the back of earnings growth and price strength, reinforcing the market’s view that fundamentals remain solid. Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch
• Positive Sentiment: Cantor Fitzgerald kept an overweight rating on HCA even after lowering its price target, signaling continued confidence in the stock’s upside potential. Benzinga coverage
• Neutral Sentiment: HCA Florida and HCA Missouri announced several hospital leadership changes, including new CEOs and a new COO, which appear to be routine management moves rather than a material financial catalyst. HCA Florida hospital taps new COO
• Neutral Sentiment: News that Williamson Health is evaluating bids from multiple healthcare companies, including HCA, does not yet indicate a direct financial impact on the company. Williamson Health evaluates bids from 3 healthcare giants
• Negative Sentiment: Cantor Fitzgerald lowered its price target for HCA from $588 to $525, which may temper some near-term enthusiasm despite the maintained bullish rating. Cantor Fitzgerald Has Lowered Expectations for HCA Healthcare (NYSE:HCA) Stock Price

HCA Healthcare Stock Up 1.4%

HCA Healthcare stock opened at $423.06 on Wednesday. The firm’s fifty day moving average is $399.31 and its 200 day moving average is $461.62. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52. The company has a market cap of $93.85 billion, a price-to-earnings ratio of 14.55, a PEG ratio of 1.32 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter last year, the firm posted $6.45 EPS. HCA Healthcare’s revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th were issued a $0.78 dividend. The ex-dividend date was Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s dividend payout ratio is presently 10.73%.

Analysts Set New Price Targets

HCA has been the topic of a number of analyst reports. Wall Street Zen cut HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, May 2nd. Truist Financial set a $413.00 price target on shares of HCA Healthcare in a research report on Thursday, June 4th. Sanford C. Bernstein lowered their target price on shares of HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating on the stock in a research note on Thursday, June 4th. JPMorgan Chase & Co. cut their price target on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a research note on Tuesday, May 19th. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a research note on Tuesday, April 28th. Fifteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $500.27.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.